CKD Prediction in HIV+ Patients
Determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.
Critical Actions
- Patients with low scores (0 points) may be good candidates for tenofovir.
- Patients with high scores (≥9 points) should avoid tenofovir in their treatment regimen, given their significantly higher risk of developing CKD within 5 years.